Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Reproductive Biology and Endocrinology

Fig. 5

From: Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood

Fig. 5

Effects of the ETG vaginal ring on the percentages of CXCR4+ and CCR5+ cells in peripheral blood and endocervical T cells. Women were treated with the ETG vaginal ring as described. PBMCs and endocervical cells were isolated at enrollment and approximately 3–4 weeks later. The percentages of CXCR4+ cells and CCR5+ cells in peripheral blood (a) and endocervical CD4+ and CD8+ T cells (b) were analyzed using flow cytometry. Data were analyzed using Wilcoxon testing and are presented as median and interquartile range (n = 16). BT: before treatment

Back to article page